Hippocampal neurogenesis is implicated in regulation of plasticity, learning and memory and experience in novel environments. However, the role of neurogenesis in learning and memory deficits and in Alzheimer's disease (AD), a neurodegenerative disease characterized by loss of memory and cognitive decline, is not fully elucidated. We have shown that hippocampal neurogenesis is impaired early in life in animal models of Familial Alzheimer's disease (FAD). Deficits in neurogenesis precede onset of hallmarks and onset of learning and memory impairments, suggesting that defective neurogenesis may play a role in the development of cognitive decline. In addition, we have shown that experience of mice in environmental enrichment rescues impaired neurogenesis and attenuate neuropathology. However, it is not clear whether impairments in neurogenesis in AD are causative and whether up regulation of neurogenesis would rescue cognitive deficits. To address that, we generated mouse models, in which neurogenesis is regulatable. Specifically, ablation of neurogenesis in APPswe/PS1?E9 was achieved by ganciclovir-induced depletion of neural progenitor cells expressing a modified version of the herpes simplex virus thymidine kinase (APPswePS1?E9/nestin-?-HSV-TK mice). Enhancement of neurogenesis in APPswe/PS1?E9 mice was achieved by tamoxifen-induced ablation of Bax in neural progenitor cells (APPswePS1?E9/nestin-CreERT2/Baxlox/lox mice). In a preliminary study we show that ganciclovir-treated APPswePS1?E9/nestin-?-HSV-TK mice exhibit significantly reduced extent of neurogenesis accompanied by deficits in contextual encoding, pattern separation and novel object recognition, as early as three months of age. Intriguingly, we observed more amyloid deposition in the hippocampus of these mice compared to vehicle-treated APPswePS1?E9/nestin-?-HSV-TK or APPswePS1?E9 mice. Taken together, these observations suggest the hypothesis that impaired hippocampal neurogenesis plays a key role in the development of cognitive deficits and neuropathology in AD, and that enhancement of neurogenesis would restore these deficits. Experiments will determine the effect of loss or gain of neurogenesis in FAD mice on extent of proliferation, survival and cell fate determination of hippocampal neural progenitor cells and new neurons (Specific Aim 1), progression of neuropathology (Specific Aim 2) and learning and memory (Specific Aim 3).
In Specific Aim 4 we will examine the association between extent of neurogenesis, level of cognitive function and neuropathology in human brain tissue of Mild Cognitive Impairment (MCI) and AD patients. These experiments will determine the role of neurogenesis in AD and lead to the development of neurogenesis-based treatment of cognitive deficits in the disease.

Public Health Relevance

This project will establish the role of adult hippocampal neurogenesis in cognitive decline and neuropathology in Alzheimer's disease in mouse models of modulated neurogenesis in Alzheimer's disease as well as in human brain tissue of Alzheimer's patients.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
3R01AG033570-07S1
Application #
9113271
Study Section
Cell Death in Neurodegeneration Study Section (CDIN)
Program Officer
Petanceska, Suzana
Project Start
2016-03-15
Project End
2019-02-28
Budget Start
2016-03-15
Budget End
2017-02-28
Support Year
7
Fiscal Year
2016
Total Cost
$53,630
Indirect Cost
$16,479
Name
University of Illinois at Chicago
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Bartolotti, Nancy; Disouky, Ahmed; Kalinski, Arthur et al. (2018) Phytochemicals from Achillea fragrantissima are Modulators of A?PP Metabolism. J Alzheimers Dis 66:1425-1435
Kuttner-Hirshler, Yafit; Venkatasubramanian, Palamadai N; Apolinario, Joan et al. (2017) Brain Biomarkers in Familial Alzheimer's Disease Mouse Models. J Alzheimers Dis 60:949-958
Hollands, Carolyn; Tobin, Matthew Kyle; Hsu, Michael et al. (2017) Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer's disease by compromising hippocampal inhibition. Mol Neurodegener 12:64
Lamotte, Guillaume; Shah, Raj C; Lazarov, Orly et al. (2017) Exercise Training for Persons with Alzheimer's Disease and Caregivers: A Review of Dyadic Exercise Interventions. J Mot Behav 49:365-377
Bartolotti, N; Bennett, D A; Lazarov, O (2016) Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells. Mol Psychiatry 21:1158-66
Hollands, Carolyn; Bartolotti, Nancy; Lazarov, Orly (2016) Alzheimer's Disease and Hippocampal Adult Neurogenesis; Exploring Shared Mechanisms. Front Neurosci 10:178
Lazarov, Orly; Hollands, Carolyn (2016) Hippocampal neurogenesis: Learning to remember. Prog Neurobiol 138-140:1-18
Bartolotti, Nancy; Segura, Laura; Lazarov, Orly (2016) Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice. J Alzheimers Dis 50:477-89
Bonds, Jacqueline A; Kuttner-Hirshler, Yafit; Bartolotti, Nancy et al. (2015) Presenilin-1 Dependent Neurogenesis Regulates Hippocampal Learning and Memory. PLoS One 10:e0131266
Demars, Michael P; Hollands, Carolyn; Zhao, Kai Da Tommy et al. (2013) Soluble amyloid precursor protein-* rescues age-linked decline in neural progenitor cell proliferation. Neurobiol Aging 34:2431-40

Showing the most recent 10 out of 22 publications